Comparison of MPC-6827 activity in xenograft models with different dosing schedules

Autor: Robert O. Carlson, D. I. Papac, K. H. Zavitz, Vijay Baichwal, G. G. Mather, Leslie Reeves, Andrew P. Beelen, Chad Bradford, J. T. Jones
Rok vydání: 2011
Předmět:
Zdroj: Journal of Clinical Oncology. 29:e13080-e13080
ISSN: 1527-7755
0732-183X
DOI: 10.1200/jco.2011.29.15_suppl.e13080
Popis: e13080 Background: MPC-6827 is a small molecule microtubule disrupting agent that is being evaluated in phase II studies for the treatment of glioblastoma multiforme. It crosses the blood-brain bar...
Databáze: OpenAIRE